RARRES1 and focal segmental glomerulosclerosis: In mouse models of focal segmental glomerulosclerosis and diabetic kidney disease, podocyte-specific overexpression of RARRES1, but not of its cleavage mutant, exacerbated albuminuria, glomerular dysfunction, and tubular injury, pointing to soluble RARRES1 as the main factor responsible for the reported effects (9).